Vyant Bio Inc reports results for the quarter ended in March - Earnings Summary

Vyant Bio

16/05/2022 22:02

* Vyant Bio Inc  VYNT.OQ  reported a quarterly adjusted loss
of 32
cents​​ per share for the quarter ended in March. The lone
analyst forecast for the quarter was for a loss of 16 cents per
share.
    * Revenue was $303.00 thousand​;  analysts expected $300.00
thousand. 
    * Vyant Bio Inc's reported EPS for the quarter was a loss
of 32
cents​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vyant Bio Inc shares had fallen by 53.6% this quarter and
lost 50.8% so far this year.
    * The company reported a quarterly loss of $9.16 million.
    * Wall Street's median 12-month price target for Vyant Bio
Inc is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 09:02 p.m.  ​All
figures in US dollars unless otherwise stated